Most Indian pharma firms are of late depending on active pharmaceutical ingredients (API) or raw material for medicine from Chinese companies, raising concern in the Indian government. According to a pharma industry body, Indian pharma companies secure 70-75 per cent of APIs from China.
Read more: 8 Chinese companies get notices for poor quality of APIs